Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 7Terminated 2Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma 5Leiomyosarcoma 2Liposarcoma, Myxoid 1Liposarcoma 1Leiomyosarcoma Uterus 1Chondrosarcoma, Mesenchymal 1

Interventions

Doxorubicin 4pembrolizumab 3Specimen Handling 3toripalimab 2Ifosfamide 2Biopsy 2silmitasertib 1selinexor 1peposertib 1pemigatinib 1pazopanib 1palbociclib 1mirdametinib 1liposomal doxorubicin 1abemaciclib 1X-Rays 1Vincristine 1Trabectedin 1Temozolomide 1Surgical Procedures, Operative 1Radiotherapy 1Quality of Life 1Proton Therapy 1Neoadjuvant Therapy 1Magnetic Resonance Spectroscopy 1Irinotecan 1Injections 1Histamine H2 Antagonists 1Gemcitabine 1Famotidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Liposarcoma × Trabectedin × Clear all
NCT02275286 2023-05-31

TRASTS

Grupo Espanol de Investigacion en Sarcomas

Phase 1/2 Recruiting
199 enrolled
Sarcoma

Leiomyosarcoma, Liposarcoma, Sarcoma, Liposarcoma, Myxoid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡